Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by riverrowon Jul 30, 2017 8:59am

100 Views

Post# 26526178

RE:TLT clinical trail conundrum

Thank you for a very interesting post. Unfortunately your statement "The only entirely harmless drug I know of is Paracetamol (Tylenol) is quite incorrect. In severe cases, an overdose of acetaminophen can cause liver failure or death. Read more at https://www.healthline.com/health/acetaminophen-overdose#Overdose2

Bullboard Posts

Consumer advocacy law firm investigates Microsoft over X-Box data concerns